Novelion Therapeutics Inc (NASDAQ:NVLN)

Delayed Data
As of 4:00pm ET
 +0.05 / +1.48%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Novelion Therapeutics Inc have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 8.00. The median estimate represents a +162.39% increase from the last price of 3.43.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Outperform stock in Novelion Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Outperform rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 0.62%


Growthquarterly --
Growthannually 7.28%
Key to the earnings and sales forecast charts.